Myeloma Clinical Trial News

Daratumumab Clinical Trial News: Added Value in Frontline and Important Implications for Patients

The addition of daratumumab (Darzalex) to standard frontline myeloma treatment in Europe extended progression-free survival in a clinical trial, reports the drug’s makers Genmab/Janssen. In this week’s blog, IMF Chairman Dr. Brian Durie spells out the broader implications of the new data: Could this new regimen challenge the current standard of care? And what about cost? The arrival of so many new myeloma treatments offers hope, yet demands scrutiny. “Evaluating these choices fully armed with the facts is proof positive that knowledge is power.” Read Dr. Durie’s blog.

FDA Approves First Ever CAR T-Cell Therapy in the United States

On Wednesday, the Food and Drug Administration (FDA) approved a new CAR T-cell therapy to treat children and young adults with relapsed acute lymphoblastic leukemia. The drug, manufactured by Novartis, will be marketed as Kymriah. Read Dr. Durie's blog from July that discusses what this approval may mean for myeloma patients.

Join This FREE Webinar on Myeloma Tests and Results

Join the IMF’s Medical Editor Debbie Birns for a “Living Well with Myeloma” webinar on Making Sense of Tests and Results. Debbie will outline the various tests that are used to diagnose myeloma, monitor response to treatment, and detect side effects. This sixty-minute webinar occurs on Thursday, September 14th, 2017 at 4 PM PT / 7 PM ET and includes a question-and-answer session. Pre-register today for FREE.

Register NOW for the IMF Patient & Family Seminar in Dallas, Texas

An IMF Patient and Family Seminar will  take place during the weekend of October 6th and 7th, 2017 at The Westin Galleria in Dallas, Texas (13340 Dallas Parkway). You may register for one or both days of the event. The expert speakers include Dr. Brian Durie (Cedars-Sinai Samuel Oschin Comprehensive Cancer Institute), Dr. Rafat Abonour (Indiana University School of Medicine), Dr. Craig Cole (Michigan University Cancer Center), Dr. Larry Anderson (UT Southwestern Medical Center) and Dr. Saad Usmani (Levine Cancer Institute).

Save the Date: The IMF's 11th Annual Comedy Celebration - Saturday, November 4th, 2017

The IMF’s 11th Annual Comedy Celebration will be held on Saturday, November 4th, 2017 in Los Angeles, CA.  Ray Romano will host a cast of stellar comedians and performers in raising funds for the Peter Boyle Research Fund supporting the IMF’s groundbreaking Black Swan Research Initiative®. This year, we’re excited to announce that members from around the world will be able to participate remotely, as the evening’s silent auction will take place ONLINE simultaneously! To register for the online auction, to receive updates from the event, or to buy tickets, journal ads, or sponsorships, visit the event site at comedy.myeloma.org.

Can myeloma cells contaminate a patient’s stem cells that are harvested for transplant?

In this week’s video, Dr. Brian GM Durie explains why the risk of myeloma cells in the blood re-infused during transplant is low and unlikely to be harmful.

 

 


We Thank Our Sponsors: Amgen, Celgene Corporation, Genentech, Janssen Pharmaceuticals, and Takeda Oncology